1H-吲哚-3-羧酸肼 | 15317-58-5

• 物质功能分类: 有机原料 - 肼或胲的有机衍生物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 1H-吲哚-3-羧酸肼
• 中文别名: 吲哚-3-甲酰肼
• 英文名称: 1H-indole-3-carboxylic acid hydrazide
• 英文别名: indole-3-carbohydrazide；1H-indole-3-carbohydrazide；indole-3-formyl hydrazide
• CAS: 15317-58-5
• 化学式: C₉H₉N₃O
• mdl: MFCD00464063
• 分子量: 175.19
• InChiKey: QHUYDKZSGDJDSC-UHFFFAOYSA-N

物化性质

• 熔点：
  224-226 °C (decomp)
• 密度：
  1.353±0.06 g/cm3(Predicted)
• 溶解度：
  DMSO（少量）、乙醇（轻微、加热、超声处理）

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  70.9
• 氢给体数：
  3
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2933990090
• 危险品标志：
  Xi
• 储存条件：
  室温且干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1H-Indole-3-carboxylic acid hydrazide
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1H-Indole-3-carboxylic acid hydrazide
CAS number: 15317-58-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H9N3O
Molecular weight: 175.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1H-吲哚-3-羧酸肼 在 碘苯二乙酸 作用下， 以 乙醇 、 乙腈 为溶剂， 反应 6.0h， 生成 2-(5-bromo-1H-indol-3-yl)-5-(1H-indol-3-yl)-1,3,4-oxadiazole
  参考文献：
  名称：

  匹林宁生物碱作为抗植物病毒的新药的发现

  摘要：

  植物病毒性疾病导致农作物产量和质量大幅下降。天然产物一直是药用和农业化学中铅发现的宝贵来源。制备了一系列嘧啶碱生物碱及其衍生物，并通过核磁共振（NMR）光谱和高分辨率质谱（HR-MS）进行了鉴定。首次系统地研究了这些生物碱对烟草花叶病毒（TMV）的抗病毒活性。大多数化合物显示出比利巴韦林更高的抗病毒活性。化合物5l，9h和10h具有比宁南霉素（也许是目前使用最广泛的抗病毒药）相似或更高的抗病毒活性，已成为新的抗病毒先导化合物。这项系统的结构-活性-关系研究为简化这些生物碱的结构奠定了基础。还发现开环产物酰基hydr 9a - 9u具有良好的抗病毒活性。此外，所有合成的化合物均表现出广谱杀真菌活性。该研究为吡皮氨酸生物碱作为新型抗病毒药物的研究和开发提供了重要的信息。

  DOI：

  10.1021/acs.jafc.8b06175
• 作为产物：
  描述：

  吲哚-3-甲酸乙酯 在 一水合肼 作用下， 以 乙醇 为溶剂， 反应 4.0h， 以85%的产率得到1H-吲哚-3-羧酸肼
  参考文献：
  名称：

  2-Arylamino-5- (3'-Indolyl)-1,3,4-Oxadiazoles 作为有效细胞毒性剂的合成和生物学评价

  摘要：

  合理简单：药物化学中的两个关键支架，吲哚和 1,3,4-恶二唑环系统的偶联产生具有 IC 的 2-芳基氨基-5-(3'-吲哚基)-1,3,4-恶二唑针对一组肿瘤细胞系，在纳摩尔范围内有50 个值。初步的构效关系研究表明，通过进一步操纵恶二唑 C-2 和 C-5 位置可以提高选择性。

  DOI：

  10.1002/cmdc.201300221

文献信息

• [EN] INHIBITORS OF HEPATITIS C VIRUS REPLICATION<br/>[FR] INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'HÉPATITE C
  申请人：MERCK SHARP & DOHME

  公开号：WO2010111483A1

  公开（公告）日：2010-09-30

  The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

  本发明涉及一种公式（I）的化合物，该化合物可用作丙型肝炎病毒（HCV）NS5A抑制剂，以及该类化合物的合成，以及利用该类化合物抑制HCV NS5A活性，用于治疗或预防HCV感染，以及在基于细胞的系统中抑制HCV病毒复制和/或病毒产生。
• Ultrasound-assisted, one-pot, three-component synthesis and antibacterial activities of novel indole derivatives containing 1,3,4-oxadiazole and 1,2,4-triazole moieties
  作者：Zhichuan Shi、Zhigang Zhao、Meiwei Huang、Xiaolin Fu

  DOI：10.1016/j.crci.2015.09.005

  日期：2015.12

  Résumé Thirteen novel indole derivatives were efficiently synthesized through ultrasound irradiation by using 4-amino-5-(1H-indol-3-yl)-4H-[1,2,4]triazole-3-thiol (8) and 2-mercapto-5-substituted-1,3,4-oxadiazoles (5a–m). Compared with conventional and microwave methods, yields increased to 82–93%, and reaction times decreased to 15–35 min. The structures of these novel compounds were characterized by spectral data and elemental analysis. Two out of the synthesized compounds (10f and 10l) exhibited excellent activity against Staphylococcus aureus and Escherichia coli, and thus warrant further research. Supplementary Materials: Supplementary material for this article is supplied as a separate file: mmc1.pdf

  摘要 通过超声辐照，以4-氨基-5-(1H-吲哚-3-基)-4H-[1,2,4]三唑-3-硫醇(8)和2-巯基-5-取代的-1,3,4-噁二唑(5a–m)为原料，高效合成了十三种新型吲哚衍生物。与传统方法和微波方法相比，产率提高到82–93%，反应时间缩短到15–35分钟。这些新化合物的结构通过光谱数据和元素分析得到表征。合成的化合物中有两种(10f和10l)对金黄色葡萄球菌和大肠杆菌显示出优异的活性，因此值得进一步研究。 补充材料： 本文的补充材料以单独文件形式提供：mmc1.pdf
• Synthesis of novel indole derivatives containing double 1,3,4-oxadiazole moiety as efficient bactericides against phytopathogenic bacterium Xanthomonas oryzae
  作者：Kun Tian、Xiao-Qin Li、Li Zhang、Yi-Yuan Gan、Jiao Meng、Shou-Qun Wu、Jin-Lin Wan、Yang Xu、Chao-Ting Cai、Gui-Ping Ouyang、Zhen-Chao Wang

  DOI：10.1007/s11696-018-0555-y

  日期：2019.1

  derivatives containing double 1,3,4-oxadiazole moiety was designed, synthesized and evaluated for their antibacterial activities in vitro. These compounds were fully characterized by 1H NMR, 13C NMR, and HRMS. Bioassay results indicated that most of title compounds exhibited excellent antibacterial activities against rice bacterial pathogen Xanthomonas oryzae (Xoo). For example, compounds 7d, 7h, 7i

  摘要设计，合成了一系列含有双1,3,4-恶二唑部分的新型吲哚衍生物，并对其体外抗菌活性进行了评估。这些化合物通过1 H NMR，13 C NMR和HRMS进行了充分表征。生物测定结果表明，大多数标题化合物对水稻细菌病原体米黄单胞菌（Xanthomonas oryzae，Xoo）均表现出优异的抗菌活性。例如，化合物7d，7h，7i，7j，7k，7l和7m具有最大有效浓度的一半（EC 50）值分别为52.31、54.12、40.65、38.80、51.13、52.75和50.66 µg / mL，优于商品化的比美噻唑（BMT）（85.18 µg / mL）。实验结果证明，带有双1,3,4-恶二唑单元的吲哚衍生物有望成为开发新型农用杀菌剂以对抗致病菌Xoo的候选物。 图形概要
• Design, Synthesis, and Pharmacological Evaluation of First‐in‐Class Multitarget <i>N</i> ‐Acylhydrazone Derivatives as Selective HDAC6/8 and PI3Kα Inhibitors
  作者：Daniel A. Rodrigues、Fabiana S. Guerra、Fernanda S. Sagrillo、Pedro Sena M. Pinheiro、Marina A. Alves、Sreekanth Thota、Lorrane S. Chaves、Carlos M. R. Sant'Anna、Patrícia D. Fernandes、Carlos A. M. Fraga

  DOI：10.1002/cmdc.201900716

  日期：2020.3.18

  phosphatidylinositol 3-kinases (PI3Ks) is a very promising approach for cancer treatment. This manuscript describes the design, synthesis, in vitro pharmacological profile, and molecular modeling of a novel class of N-acylhydrazone (NAH) derivatives that act as HDAC6/8 and PI3Kα dual inhibitors. The surprising selectivity for PI3Kα may be related to differences in the conformation in the active site

  靶向组蛋白脱乙酰基酶（HDACs）和磷脂酰肌醇3-激酶（PI3Ks）是一种非常有前途的癌症治疗方法。该手稿描述了充当HDAC6 / 8和PI3Kα双重抑制剂的新型N-酰基hydr（NAH）衍生物的设计，合成，体外药理学特征和分子模型。对PI3Kα的惊人的选择性可能与活性位点的构象差异有关。细胞研究表明，这些化合物在HDAC6抑制和PI3 / K / AKT / mTOR途径中起作用。选择性抑制HDAC6 / 8和抑制PI3Kα的化合物显示出治疗癌症的潜力。
• INHIBITORS OF HEPATITIS C VIRUS REPLICATION
  申请人：Merck Sharp & Dohme Corp.

  公开号：US20190127365A1

  公开（公告）日：2019-05-02

  The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

  本发明涉及一种具有式（I）的化合物，该化合物可用作丙型肝炎病毒（HCV）NS5A抑制剂，以及该类化合物的合成，以及利用该类化合物抑制HCV NS5A活性，用于治疗或预防HCV感染，以及在基于细胞的系统中抑制HCV病毒复制和/或病毒产生。